tetano
Editor, Senior Moderator
Pediatr Ann
. 2023 Mar;52(3):e83-e88.
doi: 10.3928/19382359-20230119-01. Epub 2023 Mar 1.
COVID-19 Vaccines for Children: An Update
Alix Rosenberg, Muskaan Sawhney, Henry H Bernstein, José R Romero
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has had a large effect on the pediatric population, with 16,000,000 cases and counting. Currently, there are two messenger RNA (mRNA)-based and a single adjuvanted, protein-based COVID-19 vaccine approved for use in children and adolescents in the United States. Multiple studies have highlighted that these vaccines are safe for use in children and adolescents and are effective at reducing COVID-19 infection and complications. Given the risk of the SARS-CoV-2 virus to the pediatric population and ongoing global viral transmission, it is advised that providers emphasize the value of COVID-19 vaccination for children and adolescents. [Pediatr Ann. 2023;52(3):e83-e88.].
. 2023 Mar;52(3):e83-e88.
doi: 10.3928/19382359-20230119-01. Epub 2023 Mar 1.
COVID-19 Vaccines for Children: An Update
Alix Rosenberg, Muskaan Sawhney, Henry H Bernstein, José R Romero
- PMID: 36881800
- DOI: 10.3928/19382359-20230119-01
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has had a large effect on the pediatric population, with 16,000,000 cases and counting. Currently, there are two messenger RNA (mRNA)-based and a single adjuvanted, protein-based COVID-19 vaccine approved for use in children and adolescents in the United States. Multiple studies have highlighted that these vaccines are safe for use in children and adolescents and are effective at reducing COVID-19 infection and complications. Given the risk of the SARS-CoV-2 virus to the pediatric population and ongoing global viral transmission, it is advised that providers emphasize the value of COVID-19 vaccination for children and adolescents. [Pediatr Ann. 2023;52(3):e83-e88.].